KRAS and acute myeloid leukemia: Strikingly, the study of acral melanoma also identified recurrent driver mutations in RTK/RAS signaling genes, including PTPN11, KIT, NF1, KRAS, and NRAS, all of which are recurrent in human AML (and commonly associated with NPM1c mutations).